Streetbeat News

Stock Prices

ELF

e.l.f. Beauty reported better-than-expected Q2 results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 10:44 am

CMBM

Cambium Networks reported worse-than-expected Q2 results, leading to a drop in its share price.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 10:44 am

ROVR

Rover Group's shares are trading higher following the company's Q2 results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 10:44 am

ABOIF

CCEP

KO

Coca-Cola Europacific Partners PLC (CCEP) and Aboitiz Equity Ventures Inc (ABOIF) plan to jointly acquire Coca-Cola Beverages Philippines from The Coca-Cola Company (KO) for $1.8 billion. The deal will make CCEP the world's largest Coca-Cola bottler by revenue and volume. Post-acquisition, the ownership structure will be 60:40 between CCEP and AEC. The transaction is expected to close by the end of FY23. CCEP also reported H1 FY23 revenue growth of 8.5% Y/Y and raised its FY23 guidance.

Portfolio Pulse from Lekha Gupta

August 04, 2023 | 10:44 am

OTLY

JP Morgan analyst Ken Goldman has downgraded Oatly Group (NASDAQ:OTLY) from Overweight to Neutral.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 10:44 am

CEQP

JP Morgan analyst Jeremy Tonet has downgraded Crestwood Equity Partners (NYSE:CEQP) from Neutral to Underweight and lowered the price target from $30 to $28.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 10:43 am

CALB

Keefe, Bruyette & Woods analyst Wood Lay has upgraded California Bancorp (NASDAQ:CALB) from Market Perform to Outperform.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 10:43 am

FRSH

Freshworks reported better-than-expected Q2 results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 10:43 am

MESO

Mesoblast has requested a trading halt pending an announcement related to the FDA's review of its Biologics License Application resubmission for Remestemcel-l, a treatment for children with steroid-refractory acute graft versus host disease. The halt on U.S. shares took effect at 7PM ET on Tuesday.

Portfolio Pulse from Charles Gross

August 04, 2023 | 10:43 am

AAPL

Weak demand for iPhones in the US and South America, and flat demand in China, could lead to Apple Inc.'s largest Q3 revenue drop since 2016. The slowdown is attributed to a weak economy and anticipation for the iPhone 15 series launch in September. The Americas region is expected to see a 6% revenue decline, with iPhone revenue expected to decline by 2% overall.

Portfolio Pulse from Rounak Jain

August 04, 2023 | 10:42 am